Publications by authors named "R ENGEL"
Objective: The aim of this study was to describe the demographic and clinical characteristics of patients with scoliosis from Australian primary care practices.
Methods: A retrospective review of 190 patient records from August 2017 to April 2020 from a private Australian clinical advisory service database was performed. Deidentified demographic and clinical data were collated and analyzed, along with information regarding the referring practitioners and any accompanying clinical or paraclinical information.
Article Synopsis
- * The study introduces enhanced modeling techniques for neutrino flux and detector response, and it distinguishes between starting (inside) and throughgoing (outside) neutrino interaction events to improve energy resolution.
- * The findings indicate a best-fit point for the 3+1 model with sin²(2θ_{24})=0.16 and Δm_{41}²=3.5 eV², supporting previous studies while showing consistency with no evidence of sterile neutrinos, as reflected
Background: The posture of performance-oriented sport climbers adapts in a way that likely promotes the development of low back pain. The thoracolumbar fascia, while also contributing to performance, seems to be involved in that process. Furthermore, there has been evidence of the stiffening of the fascial structures in disorders associated with negative affectivity.
View Article and Find Full Text PDFArticle Synopsis
- - The study compared the effectiveness of positron emission tomography (PET) combined with computed tomography (CT) versus CT alone for staging colorectal cancer (CRC) in nodal involvement and distant metastasis before treatment.
- - Results indicated that PET/CT had higher sensitivity in detecting both lymph node involvement (66.7% vs. 55.2%) and distant metastases (82.5% vs. 53.6%) compared to CT alone.
- - The findings suggest that PET/CT is a more accurate staging tool for CRC, making it valuable for treatment planning and potentially improving patient outcomes.
Article Synopsis
- Cognitive deficits significantly impact individuals with schizophrenia spectrum disorders (SSDs), and while antipsychotics are commonly used, they don’t enhance cognition and vary in their effectiveness based on their receptor profiles.
- The study aimed to assess the relationship between various antipsychotic treatments and cognitive performance in SSD patients by analyzing numerous randomized clinical trials.
- Findings showed that while no specific antipsychotic consistently performed better than placebo in improving cognition, collectively, antipsychotics had a small positive effect on cognitive outcomes compared to no treatment.